The Myeloid Meeting is a premier conference in Cincinnati, Ohio, advancing research, treatment, and collaboration in myeloid malignancies, including CH, MDS, and AML

Key Information

Nature Immunology - Grimes and colleagues integrate multiomic features to create a framework that allows the isolation of discrete cell states across hematopoiesis and exploit the underlying gene...

ASH Commits More than $12 Million to Address Research Threats

Broad dysregulated splicing in AML partially phenocopies splicing factor mutations, is prognostic, and can be pharmacologically reversed.

Follow President Donald Trump’s impact on U.S. research and science globally

Nature Immunology - In this Review, Herro and Grimes summarize the most recent key findings surrounding protective versus pathogenic functions of neutrophils, elaborating on phenotype-specific...

Cincinnati Children’s Hospital invites applications for tenure-track faculty positions at the Assistant, Associate, or Full Professor level.

Acute myeloid leukemia (AML) is a multi-clonal disease, existing as a milieu of clones with unique but related genotypes as initiating clones acquire subsequent mutations. However, bulk sequencing can...

Analysis of exomes and transcriptomes from 100 African American patients with acute myeloid leukemia identifies ancestry-related variation in mutation profiles and survival. Refined risk classificatio...